HS
Hocine Sidi Said
About Hocine Sidi Said
Data last updated:
Hocine Sidi Said is a Director at Bharath Home Medicare Private Limited (since 2019). The companies operate in Healthcare and Pharma. Bharath Home Medicare Private Limited reported revenue of ₹27.95 Cr (FY 2024). Earlier, Hocine Sidi Said was a Director at Celon Laboratories Private Limited (2020–2025) and Director at Glenmark Pharmaceuticals Limited (2009–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bharath Home Medicare Private Limited U74994TN2018PTC121604 | Director | 21 Mar 2019 | 2018 | ₹27.95 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Celon Laboratories Private Limited U24232TG2001PTC036097 | Director | 13 Nov 2020 | 2001 | ₹148 Cr (FY 2025) | Active |
 Glenmark Pharmaceuticals Limited L24299MH1977PLC019982 | Director | 29 Oct 2009 | 1977 | ₹17,443 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hocine Sidi Said
| Name | DIN | Company | Designation |
|---|---|---|---|
| Muthukumarasamy Saravanan | 06758244 | Bharath Home Medicare Private Limited | Director |
| Perumal Kannan | 08698381 | Bharath Home Medicare Private Limited | Director |
| Rajiv Nakani | 02272738 | Bharath Home Medicare Private Limited | Director |
| Varadharajan Krishnamoorthy | 08091402 | Bharath Home Medicare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hocine Sidi Said
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hocine Sidi Said
Hocine Sidi Said currently holds 1 directorship: Bharath Home Medicare Private Limited (Director, since 21 Mar 2019, revenue ₹27.95 Cr (FY 2024)).
Hocine Sidi Said was first appointed on 29 Oct 2009 as Director at Glenmark Pharmaceuticals Limited. The most recent appointment on record is 13 Nov 2020 at Celon Laboratories Private Limited.
Hocine Sidi Said held 2 earlier board appointments: Celon Laboratories Private Limited (Director, 13 Nov 2020 to 14 Jul 2025); Glenmark Pharmaceuticals Limited (Director, 29 Oct 2009 to 25 Nov 2014).
The current boards of Hocine Sidi Said's companies include Muthukumarasamy Saravanan (Bharath Home Medicare Private Limited), Perumal Kannan (Bharath Home Medicare Private Limited), Rajiv Nakani (Bharath Home Medicare Private Limited), Varadharajan Krishnamoorthy (Bharath Home Medicare Private Limited).